BIO-CONVERT A/S: Financial statements 2020
CVR: 39842319
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BIO-CONVERT A/S (CVR 39842319) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 143,006 and a net result of DKK 109,294. Equity in the 2020 report amounted to DKK -22,728.
- Gross Profit
- DKK 143,006
- Profit/Loss
- DKK 109,294
- Equity
- DKK -22,728
- Total Assets
- DKK 249,050
Official annual report
How creditworthy is BIO-CONVERT A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BIO-CONVERT A/S has published its interim report for the period August 24, 2018 to December 31, 2019.
About BIO-CONVERT A/S
BIO-CONVERT A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named BIO-CONVERT ApS and Nordicare Danmark ApS. The management consists of Allan Traugott Wehnert. The board consists of Peter Severin Bach (chair), Christian Torben Hill-Madsen and Henrik Rouf. The company is owned by Nordicus Partners Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -621,998 and a net result of DKK -587,511. Equity in the 2026 report amounted to DKK 2,607,707.